Welcome to the new morningstar.co.uk! Learn more about the changes and how our new features help your investing success.

AXA Framlington Biotech Fund GBP Z Acc

Investment Style Details31/10/2019
Morningstar Style Box®
Equity Style
SizeRel to Cat
Average Mkt Cap (Mil)GBP 10086-
Market Capitalisation% of Equity
Giant11.23
Large38.23
Medium26.53
Small17.07
Micro6.95
Valuations and Growth RatesEquity PortfolioRelative to Category
Price/Prospective Earnings12.690.72
Price/Book3.840.90
Price/Sales5.110.99
Price/Cash Flow12.631.05
Dividend-Yield Factor0.681.47
 
Long-Term Projected Earnings Growth10.390.67
Historical Earnings Growth19.540.74
Sales Growth6.420.48
Cash-Flow Growth2.970.48
Book-Value Growth7.010.60
 
Asset Allocation31/10/2019
Asset Allocation
 % Long% Short% Net Assets
Stock96.720.0096.72
Bond0.000.000.00
Property0.000.000.00
Cash2.040.091.95
Other1.330.001.33
World Regions31/10/2019
 % of EquityRelative to Category
United States85.260.96
Canada0.000.00
Latin America0.00-
United Kingdom1.410.75
Eurozone5.231.39
Europe - ex Euro3.941.53
Europe - Emerging0.00-
Africa0.00-
Middle East0.000.00
Japan2.032.51
Australasia0.000.00
Asia - Developed0.000.00
Asia - Emerging2.121.70
 
Sector Weightings31/10/2019
 % of EquityRelative to Category
HealthcareHealthcare100.001.01
 
Top 10 Holdings31/10/2019
 Portfolio
Total Number of Equity Holdings46
Total Number of Bond Holdings0
Assets in Top 10 Holdings51.27
NameSectorCountry% of Assets
Amgen Inc206United States8.90
Biogen Inc206United States7.81
Alexion Pharmaceuticals Inc206United States6.39
Gilead Sciences Inc206United States6.26
Biomarin Pharmaceutical Inc206United States4.26
Vertex Pharmaceuticals Inc206United States4.18
Celgene Corp206United States3.65
Seattle Genetics Inc206United States3.48
Illumina Inc206United States3.31
Regeneron Pharmaceuticals Inc206United States3.02
 
 
Advertisement
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites